Risk Factors for Febrile Neutropenia and Effectiveness of Primary Prophylaxis With Pegfilgrastim in Patients With Esophageal Cancer Treated With Docetaxel, Cisplatin, and 5-Fluorouracil

World Journal of Surgical Oncology- United Kingdom

doi 10.1186/s12957-019-1665-x

Full Text

Abstract

Available in

Categories

SurgeryOncology

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Frequency of Febrile Neutropenia in Patients Treated With Taxane/Epirubicine and Colony-Stimulating Growth Factors for Breast Cancer: Comparison of Filgrastim/Lenograstim With Pegfilgrastim

Breast Cancer Research
Cancer ResearchOncology
2007English

Cisplatin and Fluorouracil Alone or With Docetaxel in Head and Neck Cancer

New England Journal of Medicine
Medicine
2007English

Cost-Effectiveness of Prophylaxis Treatment Strategies for Febrile Neutropenia in Recurrent Ovarian Cancer Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

5-Fluorouracil Induced Severe Febrile Neutropenia and Death

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Prognostic Factors for Mortality With Febrile Neutropenia in Hospitalized Patients

The Southwest Respiratory and Critical Care Chronicles
2015English

Prophylaxis of Febrile Neutropenia With Colony-Stimulating Factors: The First 25 Years

Current Medical Research and Opinion
Medicine
2019English

Pegfilgrastim in Primary Prophylaxis of Febrile Neutropenia Following Frontline Bendamustine Plus Rituximab Treatment in Patients With Indolent Non-Hodgkin Lymphoma: A Single Center, Real-Life Experience

Supportive Care in Cancer
Oncology
2016English

Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated With Cetuximab

Drugs in R and D
Pharmacology
2011English

The Risk Factors for Febrile Neutropenia During Chemotherapy in Children With Malignancy

Paediatrica Indonesiana
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy